The relative risk of symptomatic cholelithiasis was 1.6, 0.9, and 1.4 in liraglutide, dulaglutide, and semaglutide with number needed to harm of 3.14, 16.67, and 5.56, respectively
If you need to mix the contents (some settling is normal with certain formulations), gently roll the vial between your palms or invert it slowly 2-3 times
Talk to your prescriber before combining the two
"The degree of mean weight reduction seen in SURMOUNT-2 has not been previously achieved in phase 3 trials for obesity or overweight and type 2 diabetes." Participants taking tirzepatide achieved average weight reductions of 13.4% (29.8 lb.) on the lower dose of 10 mg and 15.7% (34.4 lb.) on the higher dose of 15 mg, compared to a placebo group
The things that I didnt love about Piper were how generic and anonymous everything was - AI images and AI content fill the website, and theres no information on who the founders are or who the doctors are that serve you as a patient
Proof-of-concept clinical trials have assessed the safety and activity of ipamorelin in the context of POI symptoms